ACI’s Forum on Pharma & Biotech Patent Litigation USA

The American Conference Institute’s (ACI’s) Pharma & Biotech Patent Litigation USA forum is scheduled to take place from October 14-15, 2025 at 3 Times Square in New York, NY.  Billed as “the new US Gold Standard event for pharma and biotech patent litigation,” ACI’s Forum on Pharma and Biotech Patent Litigation USA brings together leaders in life sciences patent litigation for a two-day deep dive into winning patent litigation strategies.  ACI’s highly skilled faculty – comprised of premier in-house and law firm patent litigation counsel – will bring you up to date on the latest challenges in life sciences patent litigation.  This is your one-stop shop for updates, analyses, networking, and strategies to keep you in control of the patent.

Key highlights at this year’s event include:

• Lightning round session on emerging trends in Hatch-Waxman litigation
• Analysis of new Orange Book and related combination product patent concerns
• Dance lessons: what steps have we learned through 15 years of BPCIA litigation?
• Amgen, Cellect, Amneal, Xencor and More! Understand how these cases are game changers to your patent litigation strategies
• Pharma and biotech patents in antitrust the crosshairs: looking beyond the settlement to new anticompetitive challenges
• Remedies and damages: evaluating at the wide swath of possibilities, options, and penalties for patent infringement

Attend and gain insights into new legal theories for your patent case in chief, as well as analyses of substantive case law, and practical litigation strategies and takeaways for your next patent trial and proceedings.  Hyman, Phelps & McNamara, P.C.’s Kurt R. Karst will speak on a panel along with Polsinelli PC’s Chad Landmon and Venable LLP’s Christina Schwarz, titled “Exploring New Litigation Concerns from Amneal and the FTC’s Latest Call for Orange Book Delistings.”

FDA Law Blog is a conference media partner. As such, we can offer our readers a special 10% discount.  The discount code is: D10-999-FDA26.  You can access the conference brochure and sign up for the event here.  We look forward to seeing you at the conference!